Search for content, post, videos

Bavarian Nordic consolidates vaccine manufacturing in Denmark

The company will consolidate its manufacturing activities in Kvistgaard, Denmark with the aim of optimizing productivity and profitability. As part of this consolidation, the company will prepare the Kvistgaard facility for the future commercial production of its prostate cancer vaccine, PROSTVAC
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.